PROVIDER PROFILE · NPI 1104177096

Roxanne ReaPA-C

Physician AssistantGold Canyon, AZI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

711

Unique beneficiaries

—

Total services

1,014

Distinct HCPCS

Medicare payment

$61K

Peer benchmark

Total Medicare services vs. 2,639 Physician Assistant providers in AZ — top quintile (cohort median 341).

PRESCRIBING · PART D · 2024

Total Rx claims

5,053

Beneficiaries

—

Total drug cost

$162K

Distinct drugs

108

Brand share

16.1%

Top prescribed drugs

Levothyroxine Sodium343 claims

Losartan Potassium157 claims

Trazodone Hcl152 claims

Amlodipine Besylate150 claims

Escitalopram Oxalate150 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$985

Payment records

By payment type

Food and Beverage$985

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 037015

Home health agency

CCN 030088

Hospital

REFERRAL NETWORK

Where Roxanne Rea's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 5 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
BANNER BAYWOOD MEDICAL CENTER	15	22

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · Phoenix, AZ	96	163
Robert Allen Family Practice · Gold Canyon, AZ	86	138
CHIARADONNA, NICOLA	39	51
BANNER BAYWOOD MEDICAL CENTER	24	32
Sonora Quest Laboratories Llc Clinical Laboratory · Phoenix, AZ	21	27

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history